Opinion: Advocates engaged in litigation involving complex science must be prepared to navigate technical evidence, expert ...

Users of Microsoft Office's Word, Excel PowerPoint and Outlook will have to get used to the software suite's new name following a recent rebranding.

New high-resolution images show that novae are anything but simple stellar fireworks. One exploded with multiple gas streams colliding almost immediately, while another shockingly delayed its eruption ...

We may earn revenue from the products available on this page and participate in affiliate programs. Learn more › TL;DR: This $19.97 deal gives you the full Office Pro 2019 suite for life. From your ...

What if creating a stunning, professional presentation was as simple as having a conversation? With Microsoft PowerPoint’s Copilot, that vision is now a reality. This new AI-powered assistant is ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

News of an apparently impending sale to a strategic investor sent shares of Exact Sciences (NASDAQ: EXAS) skyward on Wednesday. The cancer diagnostics specialist's shares closed the day nearly 24% ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Exact Sciences (EXAS) one of those stocks right now? By taking a look at the ...

Add Yahoo as a preferred source to see more of our stories on Google. Image Credit: Deposit Photos. Science isn't just about textbooks and laboratories—it's an engaging journey of discovery that can ...

Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...

Sometimes you might want to add a circular photo of the author on the last page of a text or presentations. Word and PowerPoint don’t offer this feature directly, but there are two ways to achieve it.

Genenta Science's shares were under pressure Monday after the immuno-oncology company priced a roughly $15 million equity raising. In premarket trading, the shares were 34% lower on Nasdaq after ...